These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33545393)

  • 41. The arrival and spread of SARS-CoV-2 in Colombia.
    Ramírez JD; Florez C; Muñoz M; Hernández C; Castillo A; Gomez S; Rico A; Pardo L; Barros EC; Castañeda S; Ballesteros N; Martínez D; Vega L; Jaimes JE; Cruz-Saavedra L; Herrera G; Patiño LH; Teherán AA; Gonzalez-Reiche AS; Hernandez MM; Sordillo EM; Simon V; van Bakel H; Paniz-Mondolfi A
    J Med Virol; 2021 Feb; 93(2):1158-1163. PubMed ID: 32761908
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sequencing Using a Two-Step Strategy Reveals High Genetic Diversity in the S Gene of SARS-CoV-2 after a High-Transmission Period in Tunis, Tunisia.
    Fares W; Ghedira K; Gdoura M; Chouikha A; Haddad-Boubaker S; Khedhiri M; Ayouni K; Lamari A; Touzi H; Hammemi W; Medeb Z; Sadraoui A; Hogga N; Ben Alaya N; Triki H
    Microbiol Spectr; 2021 Dec; 9(3):e0063921. PubMed ID: 34756072
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genomic surveillance of SARS-CoV-2 in Thailand reveals mixed imported populations, a local lineage expansion and a virus with truncated ORF7a.
    Joonlasak K; Batty EM; Kochakarn T; Panthan B; Kümpornsin K; Jiaranai P; Wangwiwatsin A; Huang A; Kotanan N; Jaru-Ampornpan P; Manasatienkij W; Watthanachockchai T; Rakmanee K; Jones AR; Fernandez S; Sensorn I; Sungkanuparph S; Pasomsub E; Klungthong C; Chookajorn T; Chantratita W
    Virus Res; 2021 Jan; 292():198233. PubMed ID: 33227343
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pitfalls of barcodes in the study of worldwide SARS-CoV-2 variation and phylodynamics.
    Pardo-Seco J; Gómez-Carballa A; Bello X; Martinón-Torres F; Salas A
    Zool Res; 2021 Jan; 42(1):87-93. PubMed ID: 33410308
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nosocomial Outbreak of SARS-CoV-2 in a "Non-COVID-19" Hospital Ward: Virus Genome Sequencing as a Key Tool to Understand Cryptic Transmission.
    Borges V; Isidro J; Macedo F; Neves J; Silva L; Paiva M; Barata J; Catarino J; Ciobanu L; Duarte S; Vieira L; Guiomar R; Gomes JP
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33916205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic variants and source of introduction of SARS-CoV-2 in South America.
    Poterico JA; Mestanza O
    J Med Virol; 2020 Oct; 92(10):2139-2145. PubMed ID: 32401345
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genomic diversity and molecular dynamics interaction on mutational variances among RB domains of SARS-CoV-2 interplay drug inactivation.
    Uddin MB; Sajib EH; Hoque SF; Bappy MNI; Elahi F; Ghosh A; Muhit S; Hassan MM; Hasan M; Chelliah R; Park SJ; Mony TJ; Oh DH; Ahmed SSU
    Infect Genet Evol; 2022 Jan; 97():105128. PubMed ID: 34752930
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genomic diversity of SARS-CoV-2 during early introduction into the Baltimore-Washington metropolitan area.
    Thielen PM; Wohl S; Mehoke T; Ramakrishnan S; Kirsche M; Falade-Nwulia O; Trovão NS; Ernlund A; Howser C; Sadowski N; Morris CP; Hopkins M; Schwartz M; Fan Y; Gniazdowski V; Lessler J; Sauer L; Schatz MC; Evans JD; Ray SC; Timp W; Mostafa HH
    JCI Insight; 2021 Mar; 6(6):. PubMed ID: 33749660
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SARS-CoV-2 Variants in Rhode Island.
    Kantor R; Novitsky V; Carpenter-Azevedo K; Howison M; Manne A; Darpolor JK; Bobenchik A; Tripathi A; Huard RC; King E
    R I Med J (2013); 2021 Sep; 104(7):16-20. PubMed ID: 34279520
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emergence and spread of the potential variant of interest (VOI) B.1.1.519 of SARS-CoV-2 predominantly present in Mexico.
    Rodríguez-Maldonado AP; Vázquez-Pérez JA; Cedro-Tanda A; Taboada B; Boukadida C; Wong-Arámbula C; Nuñez-García TE; Cruz-Ortiz N; Barrera-Badillo G; Hernández-Rivas L; López-Martínez I; Mendoza-Vargas A; Reyes-Grajeda JP; Alcaraz N; Peñaloza-Figueroa F; Gonzalez-Barrera D; Rangel-DeLeon D; Herrera-Montalvo LA; Mejía-Nepomuceno F; Hernández-Terán A; Mújica-Sánchez M; Becerril-Vargas E; Martínez-Orozco JA; Pérez-Padilla R; Salas-Hernández J; Sanchez-Flores A; Isa P; Matías-Florentino M; Ávila-Ríos S; Muñoz-Medina JE; Grajales-Muñiz C; Salas-Lais AG; Santos Coy-Arechavaleta A; Hidalgo-Miranda A; Arias CF; Ramírez-González JE
    Arch Virol; 2021 Nov; 166(11):3173-3177. PubMed ID: 34448936
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SARS-CoV-2: Structural diversity, phylogeny, and potential animal host identification of spike glycoprotein.
    Dabravolski SA; Kavalionak YK
    J Med Virol; 2020 Sep; 92(9):1690-1694. PubMed ID: 32374452
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genomic epidemiology reveals transmission patterns and dynamics of SARS-CoV-2 in Aotearoa New Zealand.
    Geoghegan JL; Ren X; Storey M; Hadfield J; Jelley L; Jefferies S; Sherwood J; Paine S; Huang S; Douglas J; Mendes FK; Sporle A; Baker MG; Murdoch DR; French N; Simpson CR; Welch D; Drummond AJ; Holmes EC; Duchêne S; de Ligt J
    Nat Commun; 2020 Dec; 11(1):6351. PubMed ID: 33311501
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reinfection with two genetically distinct SARS-CoV-2 viruses within 19 days.
    Tang CY; Wang Y; McElroy JA; Li T; Hammer R; Ritter D; Lidl GM; Webby R; Hang J; Wan XF
    J Med Virol; 2021 Oct; 93(10):5700-5703. PubMed ID: 34170528
    [No Abstract]   [Full Text] [Related]  

  • 54. Different selection dynamics of S and RdRp between SARS-CoV-2 genomes with and without the dominant mutations.
    Koçhan N; Eskier D; Suner A; Karakülah G; Oktay Y
    Infect Genet Evol; 2021 Jul; 91():104796. PubMed ID: 33667722
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Gapless, Unambiguous RNA Metagenome-Assembled Genome Sequence of a Unique SARS-CoV-2 Variant Encoding Spike S813I and ORF1a A859V Substitutions.
    Soliman MS; AbdelFattah M; Aman SMN; Ibrahim LM; Aziz RK
    OMICS; 2021 Feb; 25(2):123-128. PubMed ID: 33253058
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Variants of concern responsible for SARS-CoV-2 vaccine breakthrough infections from India.
    Singh UB; Rophina M; Chaudhry R; Senthivel V; Bala K; Bhoyar RC; Jolly B; Jamshed N; Imran M; Gupta R; Aggarwal P; Divakar MK; Sinha S; Arvinden VR; Bajaj A; Shamnath A; Jain A; ; Scaria V; Sivasubbu S; Guleria R
    J Med Virol; 2022 Apr; 94(4):1696-1700. PubMed ID: 34786733
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative insight into the genomic landscape of SARS-CoV-2 and identification of mutations associated with the origin of infection and diversity.
    Mishra D; Suri GS; Kaur G; Tiwari M
    J Med Virol; 2021 Apr; 93(4):2406-2419. PubMed ID: 33347622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tracking down B.1.351 SARS-CoV-2 variant in Pakistan through genomic surveillance.
    Umair M; Ikram A; Badar N; Haider SA; Rehman Z; Ammar M; Ahad A; Ali Q; Suleman R; Salman M
    J Med Virol; 2022 Jan; 94(1):32-34. PubMed ID: 34499364
    [No Abstract]   [Full Text] [Related]  

  • 59. A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.
    Díez-Fuertes F; Iglesias-Caballero M; García-Pérez J; Monzón S; Jiménez P; Varona S; Cuesta I; Zaballos Á; Jiménez M; Checa L; Pozo F; Pérez-Olmeda M; Thomson MM; Alcamí J; Casas I
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33127745
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Whole genome sequencing and phylogenetic classification of Tunisian SARS-CoV-2 strains from patients of the Military Hospital in Tunis.
    Handrick S; Bestehorn-Willmann M; Eckstein S; Walter MC; Antwerpen MH; Naija H; Stoecker K; Wölfel R; Ben Moussa M
    Virus Genes; 2020 Dec; 56(6):767-771. PubMed ID: 33034798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.